Evidence Availability for Elective Stage I-III Colon Cancer
No systematic reviews or network meta-analyses specifically evaluating elective stage I-III right- or left-sided colon cancer with your exact exclusion criteria (emergency obstruction/perforation, trauma, IBD, rectal cancer) currently exist in the provided evidence.
What the Current Evidence Shows
The available guidelines and research focus predominantly on emergency presentations rather than elective resections:
Emergency-Focused Literature
All the guideline evidence provided 1, 2, 1, 2, 1, 2, 1 addresses management of obstructed or perforated colon cancer, which you explicitly exclude. These 2017-2019 WSES guidelines discuss:
- Bridge-to-surgery stenting versus emergency resection
- Hartmann's procedures versus primary anastomosis in emergency settings
- Management of unstable patients with perforation
The 2019 systematic review 2 examining international guidelines found no consensus on left-sided malignant bowel obstruction management, with only 42% recommending primary surgery, 11% stenting, and 47% suggesting either approach could be performed.
Recent Research Evidence (2024-2026)
The newer research studies do address elective colon cancer but with different focuses:
- 3 (2024): Examines complete mesocolic excision (CME) for right-sided colon cancer, finding survival benefit only in Stage III disease, not across all stages
- 4 (2026): Network meta-analysis comparing decompression strategies for left-sided malignant obstruction (emergency presentation you exclude)
- 5 (2026): Addresses right-sided malignant obstruction management (emergency presentation you exclude)
- 6 (2026): Compares surgical access routes (open vs. laparoscopic) and anastomotic techniques for right-sided resections in elective settings
- 7 (2026): Reviews extended lymphadenectomy (D3 dissection) for right-sided colon cancer
Critical Gap in the Literature
The specific population you're asking about—elective stage I-III colon cancer excluding emergencies, trauma, IBD, and rectal cancer—lacks dedicated systematic reviews or network meta-analyses. This represents a significant evidence gap, as most comparative research has focused on:
- Emergency versus elective approaches in obstructed patients
- Specific surgical techniques (CME, D3 dissection, anastomotic methods)
- Access routes (laparoscopic versus open)
Rather than comprehensive comparisons of outcomes across the full spectrum of elective stage I-III disease.
What Would Be Needed
A properly designed systematic review for your population would need to:
- Focus exclusively on planned, elective resections
- Stratify by tumor location (right versus left colon)
- Analyze outcomes by stage (I, II, III separately)
- Compare surgical approaches, extent of resection, and adjuvant therapy timing
- Exclude all emergency presentations, IBD-related cancers, and rectal cancers
This review does not currently exist in the published literature based on the evidence provided.